30 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:48 PM
Venus Remedies Ltd.

BSE

  • 97.65 0.30 (0.31%)
  • Vol: 9571
  • BSE Code: 526953
  • PREV. CLOSE
    97.35
  • OPEN PRICE
    97.20
  • BID PRICE (QTY.)
    98.05(100)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • 97.65 0.00 (0%)
  • Vol: 46721
  • NSE Code: VENUSREM
  • PREV. CLOSE
    97.65
  • OPEN PRICE
    97.90
  • BID PRICE (QTY.)
    97.65(134)
  • OFFER PRICE (QTY.)
    0.00(0)

Venus Remedies Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
11-Apr-201713-Apr-2017 This is to inform you that the meeting of Board of Directors is scheduled to be held on 13.04.2017 to inter alia appoint statutory auditor under section 139 of the Companies Act, 2013 and any other item with the permission of chair. Further, pursuant to the provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, it has been decided to close the trading window for the dealing in the securities of the company listed at your exchange with effect from April 10, 2017 to April 15, 2017 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
17-Feb-201722-Feb-2017 Venus Remedies Ltd has informed BSE that the meeting of Board of Directors is scheduled to be held on February 22, 2017, inter alia, to consider and approve raising of funds by way of Qualified Institutional Placement (QIP).
30-Jan-201708-Feb-2017 Quarterly Results & Venus Remedies Ltd has informed BSE that the meeting of Board of Directors is scheduled to be held on February 08, 2017, inter alia, to consider and approve Unaudited Financial Results (Provisional) for the quarter ended on December 31, 2016, to allot warrants/equity shares to promoters of the Company on preferential basis.
04-Nov-201609-Nov-2016 Quarterly Results
28-Jul-201606-Aug-2016 Quarterly Results & Venus Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on Saturday August 06, 2016, inter alia, to consider and approve the following; 1. Unaudited financial results (provisional) for the quarter ended June 30, 2016. 2. To issue fully convertible warrants/equity shares to promoters on a preferential basis subject to approval in the general meeting. 3. To fix the date of Annual General Meeting and book closure.
20-Jun-201624-Jun-2016 Venus Remedies Ltd has informed that a meeting of the Board of Directors of the Company will be held on June 24, 2016, inter alia, to consider the status of preferential issue of shares which was passed at last AGM, which is still pending for implementation. Further, in terms of SEBI (Prohibition of Insider Trading) Regulations, the Trading Window, for dealing in securities of the Company shall be closed from June 18, 2016 to June 26, 2016 (Both days inclusive) for all the designated employees.
24-May-201628-May-2016 Audited Results
08-Feb-201610-Feb-2016 Quarterly Results
16-Dec-201519-Dec-2015 The Board of Directors of the Company will be held on December 19, 2015, inter alia, to reconsider the relevant date for the preferential issue approved by the shareholders in AGM dated August 25, 2015.
03-Nov-201513-Nov-2015 Quarterly Results
13-Aug-201514-Aug-2015 Quarterly Results
23-Jun-201530-Jun-2015 The Board of Directors of the Company will be held on June 30, 2015, inter alia, to consider and approve following items: 1. To issue fully convertible warrants / equity shares to promoters on a preferential basis subject to approval in the general meeting. 2. To fix the date of Annual General Meeting.
02-Jun-201530-May-2015 Audited Results(Cancelled) (Cancelled)
29-May-201530-May-2015 Audited Results(Cancelled) (Cancelled)
04-Feb-201513-Feb-2015 Quarterly Results